11. Open label, prospective, post marketing trial to observe safety and efficacy of MERO DT (Meropenem + edta ) in the management of multidrug resistant bacterial infection or in various infections.

10. A Multi-Center, Prospective, Open label, Single Arm Post Market Surveillance Study to Evaluate the Safety & Efficacy of Sterile Collagen Particles [BioFil®, Helisorb, UrgoRegenerate, Bavilon, Biocollazand Unifil] (fish origin) in healing of non-infected or infection cleared Chronic Footulcers (diabetic foot ulcers).

9. An Open Label, Multicentre, Post Marketing Surveillance study to Monitor the Safety and Efficacy of Combination Therapy of Desvenlafaxine Succinate Equal to Desvenlafaxine 100mg/50mg and Clonazepam 0.5 mg/0.5mg uncoated bilayered tablet in Major Depressive with Co-Morbid Anxiety.

8. Evaluation of Efficacy and Safety of Fixed Dose Combination of (Levocetrizine HCl IP 5mg + Montelukast Sodium IP Eq. to Montelukast 10 mg + Ambroxol HCl IP 75 mg film coated tablets in Patients with Seasonal Allergic Rhinitis.

7. Evaluation of Efficacy and Safety of Fixed Dose Combination of Levocetirizine Hydrochloride and Montelukast in Patients with Seasonal Allergic Rhinitis.

6. A pilot, open label single arm prospective study to evaluate the safety and efficacy of bio-cornea of synchromax in corneal transplantation.

5. A randomised, double blind, parallel arm, placebo-controlled clinical trial to evaluate the efficacy and Safety of Anti-Anemic syrup in patients with mild-moderate iron deficiency anemia.

4. Single Arm Post Marketing Study to Evaluate Safety and Efficacy of Ambronac Tablets in Adult Bronchitis Patients with Excess Mucus Production.

3. An Open Label, Multicentre, Post Marketing Surveillance study to Monitor the Safety and Efficacy of Combination Therapy of Escitalopram 5 mg/10 mg and Etizolam 0.5 mg in Subjects with Major Depressive Disorder with Associated Anxiety in Regular Practice.

2. Single Arm Post Marketing Study to Evaluate Safety and Efficacy of Glutazene sachets (Azulene and Glutamine) in Adult Patients with Symptomatic Acid Peptic Disease.

1. An Open Label, Multicentre, Post Marketing Surveillance study to Monitor the Safety and Efficacy of Combination Therapy of Amitriptyline 12.5mg/25mg and Chlordiazepoxide 5mg/10mg in Subjects with Major Depressive Disorder with Associated Anxiety in Regular Practice.